Phasing-in RHD genotyping
- PMID: 24786114
- PMCID: PMC5178138
- DOI: 10.5858/2013-0509-ED
Phasing-in RHD genotyping
Conflict of interest statement
WAF receives royalties and holds intellectual property rights for RHD genotyping. The other authors declare no competing interests relevant to this article.
Comment on
-
Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists.Arch Pathol Lab Med. 2014 May;138(5):620-5. doi: 10.5858/arpa.2013-0141-CP. Arch Pathol Lab Med. 2014. PMID: 24786120
References
-
- Sandler SG, Roseff SD, Domen RE, Shaz BH, Gottschall JL. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin. Arch Pathol Lab Med. 2013;137(Dec 2013) in press. - PubMed
-
- Carson TH. Standards for Blood Banks and Transfusion Services. 28. Bethesda MD: AABB; 2012.
-
- Kennedy MS. Perinatal issues in transfusion practice. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical Manual. 18. Bethesda: AABB; 2012. pp. 637–650.
-
- Sandler SG, Mozurkewich EL. Ask the Experts: Postpartum Rh immunoprophylaxis. Obstet Gynecol. 2012;120 - PubMed
-
- Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood. 1999;93(1):385–393. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
